Royalty Pharma (RPRX) Asset Utilization Ratio (2020 - 2026)

Royalty Pharma has disclosed Asset Utilization Ratio across 7 years of filings, most recently posting 0.12 for Q1 2026.

• Asset Utilization Ratio for Q1 2026 came in at 0.12, down 2.05% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.12 (down 2.05% YoY), and the FY2025 annual result was 0.13, down 3.93% from the prior year.
• Asset Utilization Ratio came in at 0.12 for Q1 2026 at Royalty Pharma, up from 0.12 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.15 in Q4 2023 to a low of 0.12 in Q4 2025.
• The 5-year median for Asset Utilization Ratio is 0.13 (2022), against an average of 0.13.
• Across the five-year window, Asset Utilization Ratio rose 12.59% in 2023 and retreated 14.54% in 2024, its largest moves.
• Royalty Pharma's Asset Utilization Ratio stood at 0.13 in 2022, then grew by 12.59% to 0.15 in 2023, then retreated by 14.54% to 0.12 in 2024, then retreated by 2.22% to 0.12 in 2025, then climbed by 1.4% to 0.12 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.12 (Q1 2026), 0.12 (Q4 2025), and 0.12 (Q3 2025), per Business Quant data.